A new study has found no evidence that COVID-19 shots increase the incidence of Guillain-Barré syndrome, according to researchers. “This is important because we can say that there is no significant increased risk of Guillain-Barré syndrome in the population,” said study first author Mustafa Jaffry, a medical student at Rutgers New Jersey Medical School in New Jersey. “This information can help in ensuring confidence in vaccines, while approaching it from an objective, statistical analysis.”
After receiving initial reports of a possible connection, the U.S. Food and Drug Administration issued a warning in July 2021 that people receiving the Johnson & Johnson COVID vaccine might be at a greater risk of developing the rare neurological condition that attacks the nerves and is sometimes fatal. Guillain-Barré syndrome is often caused by a bacterial infection, so that can make tracking down the source of the syndrome more difficult. To read the full story.